Cipher Pharmaceuticals Inc CPHRF:OTCPK

RT Quote | Exchange | USD
Last | 08/16/22 EDT
1.88UNCH (UNCH)
52 week range
1.06 - 2.25
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.88
  • 52 Week High2.25
  • 52 Week High Date10/21/21
  • 52 Week Low1.06
  • 52 Week Low Date06/09/22

Key Stats

  • Market Cap46.13M
  • Shares Out25.56M
  • 10 Day Average Volume7,192.1
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change33.33

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.88
  • 52 Week High2.25
  • 52 Week High Date10/21/21
  • 52 Week Low1.06
  • 52 Week Low Date06/09/22
  • Market Cap46.13M
  • Shares Out25.56M
  • 10 Day Average Volume7,192.1
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change33.33

RATIOS/PROFITABILITY

  • EPS (TTM)0.32
  • P/E (TTM)5.87
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Cipher Pharmaceuticals Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Cipher Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products directly in Canada and indirectly through partners in the United States, Canada and South America. Its Dermatology products include Actikerall, Epuris...
Craig Mull
Chairman of the Board, Interim Chief Executive Officer
Scott Langille CPA
Chief Financial Officer
Diane Gajewczyk
Vice President - Scientific and Medical Affairs
Address
209 Oak Park Blvd, Suite 501
Oakville, ON
L6H 0M2
Canada